Skip to content

A Study on Radial Extracorporeal Shock-wave Therapy for Treating Benign Prostatic Hyperplasia

A Study on Radial Extracorporeal Shock-wave Therapy for Treating Benign Prostatic Hyperplasia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-15007432
Enrollment
Unknown
Registered
2015-11-22
Start date
2015-12-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign Prostatic Hyperplasia

Interventions

Radial extracorporeal shock-wave therapy group:Radial extracorporeal shock-wave therapy
sham group:sham radial extracorporeal shock-wave therapy

Sponsors

The First Affiliated Hospital of China Medical University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
40 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. male patients with benign prostatic hyperplasia, age>=40 years old; 2. with lower urinary tract symptoms include urinary frequency, dysuria, urgency incontinence, and nocturia; 3. post void residual (PVR) < 60 ml; and prostate hyperplasia grade I- III by suprapubic prostate ultrasound; 4. serum PSA<4 ng/ml; 5. normal coagulation function.

Exclusion criteria

Exclusion criteria: 1. evidence of bacteria in urinary and seminal culture tests; 2. prostate cancer was excluded clinically and serologically with PSA>=4 ng/ml; 3. local acute infection; 4. local acute thrombosis; 5. coagulation disorders or taking anticoagulant; 6. local malignant tumor.

Design outcomes

Primary

MeasureTime frame
International Prostate Symptom Score;maximum flow rate;quality of life;

Secondary

MeasureTime frame
mean flow rate;International Index of Erectile Function;Transrectal Ultrasound;prostatic MRI;

Countries

China

Contacts

Public ContactYuewen Ma
yeuwen_m@126.com+86 18040099516

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026